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In previous publications we have presented evidence that the first component 
of guinea pig complement  (C'I)  is synthesized by the  small  intestine  (1,  2). 
This  conclusion was based on the  observations  that,  in vitro,  small  intestine 
was the only tissue capable of production of hemolytically active C'I, that this 
production  was  reversibly  inhibited  by  puromycin  and  actinomycin  D  and 
that  a~C-lysine was  incorporated  into  molecules  which  had  the  properties  of 
C'I (C'l-like molecules)  (1).  Furthermore,  by use of a hemolytic plaque assay 
technique  (3)  adapted  to  the  study  of C'I  synthesis  by individual  ceils  (2), 
it  was  found  that  columnar  epithelial  ceils  of  the  small  intestine  were  the 
only cells capable of producing hemolytic plaques. 
We now report  that human colon as wen as ileum are sites  of synthesis  of 
C'1.  There  was  no  detectable  synthesis  of  C'I  in  any  of  the  other  tissues 
examined.  The  ceil  type producing  hemolytically active human  C'I  has  not 
yet been identified. 
Materials  and Methods 
The preparation  of partially  purified guinea pig C'2 (the second component  of C')  (4), 
the cell intermediate  EAC'4 (5) consisting of sensitized sheep exythrocytes  (E)  (4), rabbit 
antibody to boilod stromata of E  (A) (4), and fourth component of C', and C'EDTA (guinea 
pig  serum  diluted  ~0  in 0.01 ~  Na-ethylenediaminetetraacetate,  pH  7.5) (6)  have been 
described. Fresh frozen guinea pig serum was obtained from Suburban  Serum Laboratories, 
Silver Spring, Md. Isotonic Veronal-buffered saline (VBS), g  -- 0.15, and isotonic Veronal- 
buffered sucrose,/~ =  0.0090, were prepared as previously described (7). 
Assay of ¢'l.--The assay of C'I activity is based on the ability of C'I to convert EAC'4 
to EAC'la,4 (8). Tissue fragments  (average wet weight,  40 rag) were incubated  with 0.5 
ml of EAC'4 (1.5 X  10  s cell/ml)  in VBS, for 10 rain at 30°C. The second component of C' 
(C'2) and C'EDTA (to supply the late acting C' components) were added, and the number 
of C'1 molecules transferred  from  the tissue  to EAC'4 was calculated  from  the degree of 
hemolysis (9). Where the C'I content of a tissue was too high to permit its estimation in the 
one step assay described above, a  two step assay for C'1 content was performed as follows: 
Tissue fragments were incubated with 0.5 ml of EA (1.5 X 10  s cells/ml) for 10 rain at 30°C to 
permit transfer of C'I from the tissue to the EA; at this time, suitable dilutions of the EAC'I 
* A preliminary  report of this work was presented  at the Complement Workshop at the 
Harvard Medical School, Boston, Mass., 3  to 5 June 1968. 
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were incubated for 10 rain at 30°(2 with EAC'4 at ~  =  0.15 to permit transfer of the C'I from 
EAC'I to EAC'4. After addition of the remaining complement components, the amount of 
C'1 transferred was calculated from the degree of lysis. 
Preparation of Orgam.--Isolated  organs were obtained either at postmortem examinations 
within 3 to 4 hr of time of death or at surgery. Tissues were placed immediately into Ringer's 
lactate solution at 0°C. Segments of the alimentary tract, liver, spleen, kidney, lymph node, 
lungs, and thymus were washed at 0°C in Ringer's lactate solution with 5% glucose (Abbott 
Laboratories, North Chicago, Ill.) containing 100 units of aqueous crystalline penicillin and 
50 gg streptomycin/ml. At this stage of preparation, tissues contained C'I activity, probably 
due to the presence of serum (1). This initial C'1 activity was eliminated by incubating  each 
of the tissues in 0.01 g EDTA buffer for 40 rain at 37°C. The tissues were washed four times 
at 0°C in the Ringer's lactate  solution to remove EDTA and then tested for residual C'1 
activity. 
Irwubati~n MeCh.--Tissues were incubated in medium 199 containing 100 units of penicil- 
lin and 50/zg streptomycin/ml.  In experiments to test the effect of inhibitors of protein syn- 
thesis on the production of C'1, tissues were incubated in medium 199 containing puromycin 
(10-15/~g/ml)  or actinomycin DI(10-15 ~g/ml), and penicillin (100 units/ml), and strepto- 
myc~ (5o uglml). 
The incorporation  of  t4C-labeled  amino  acids  into  C'1-1ike  molecules  was studied  by incu- 
bating  EDTA-treated tissues  in  medium 199  in  which  14C-labeled  leucine  (>130  mc/mmole), 
lysine  (>180 mc/mmole), arginine  (>130 mc/mmole), and valine  (>120 mc/mmolc) (14C- 
protein-labeling  mixture,  Schwarz BioResearch Inc.,  Orangeburg, N.Y. lot No. 6801)  at a 
final  concentration  of  2/~c/ml were  substituted  for  the  corresponding  unlabeled  amino acids. 
At timed intervals  tissue  fragments  were  removed  from this  mixture,  washed  once in  medium 
199 lacking  radioactive  amino acids,  and then incubated  for 15 min at 30°C with 1.0  ml of 
EA (1 X  109  ccIl/ml).  At this  time the tissue  fragment was removed and the  red  cells  were 
washed once in VBS sucrose  buffer  (~ -  0.065),  then coUccted  by centrifugation  and resus- 
pended in  5.0  ml of  VBS-sucrose buffer.  The cell  suspension  was  divided  into  2.4  ml portions 
one of which received  10.0  ml VBS-sucrose and was incubated  for I0 rain  at 37°(2  followed 
by one wash with VBS-sucrose buffer.  The other  2.4 ml portion  received  0.24  ml of 0.1  z# 
EDTA  and I0.0  ml of 0.01  M EDTA  buffer  and was also  incubated  for 10 min at 37°C fol- 
lowed by one wash with 0.01  M EDTA  buffer.  Both cell  suspensions  were then  washed three 
times in VBS-sucrose buffer,  transferred  to Corex centrifuge  tubes,  and centrifuged.  Each 
ceU button was lysed  with 10.0  ml of  distilled  water and the  resulting  stromata  were centri- 
fuged  at  0°(2  in  a Sorvall  centrifilge  type SS 34  rotor  for  30  rain  at  39,100  g.  The sedimented 
stromata were dissolved  in NCS  reagent (Nuclear-Chicago  Corp., Des Plaines,  Ill.)  and 
transferred  quantitatively  in  a final  volume  of 1.0  ml to  counting  vials.  10 ml of  scintillation 
fluid  s  were added,  and the  radioactivity  was counted for  10  rain  in  a Packard  Tri-Carb scin- 
tUlation  spectrometer  (model 4312).  Control determinations  were performed exactly  in the 
above  manner  except  that  E were  substituted  for  EA. In  some  instances  the  amount of  hemo- 
lytically  active  C'I on EA and E was also  determined  by the  C'I transfer  test  (9). 
RESULTS 
Site of C'1  Sy~hesis--EDTA-treated portions of  transverse  colon,  ileum, 
stomach,  liver,  spleen,  and kidney obtained  at  autopsy  were  incubated  in 
1 We are indebted  to the Drug Development Branch of the Cancer Chemotherapy Na- 
tional Service Center, NCI, for supplying puromycin (NSC-3055) and actinomycin D (NSC- 
3053). 
2 Solution of  5  g  of  2,5-diphenyloxasole and 0.1  g of  1,4-bis  2-(5-phenyloxazolyl) ben- 
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medium 199 at IO°C and their C'I content was determined at timed intervals. 
The  segments of colon  and  ileum were  the  only tissues  capable of in  vitro 
production  of hemolytically active C'1  (Fig.  1).  It was  a  consistent finding 
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FIo. 1. In vitro production of hemolytically active C'I by isolated h-man tissue. Tissues 
were incubated in medium 199 at 7°C. 
TABLE I 
In Vitro Production of Hemolytically Active Ctl by Intestinal Tissues Obtained at 
Postmov~n Ecamina~ion 
IIcum * 
Jejunum 
Infarcted  segment  of  transverse 
colon 
C'l molecules (X  I0~/I00  mg  of tissue 
Time of incubation,/w 
0  17  42  66 
0.07 
0.03 
0.04 
0.50 
0.15 
0.01 
2.0 
0.04 
0.10 
0.80 
0.10 
0.05 
* Tissues incubated in medium 199 at 7°C. 
with material obtained at autopsy that the amount of C'I produced by colon 
fragments  was  significantly  greater  than  that  produced  by  the  ileum.  In 
contrast, segments of an infarcted transverse colon were incapable of in vitro 
C'I production.  Segments of ileum but not of jejunum from this patient were 
capable of in vitro Cq  production  (Table I).  The effect of temperature on 598  SYntHESIS  0~" HUMAN  cIl 
production of C'I  by segments of sigmoid colon is shown in Fig. 2.  For this 
experiment,  portions of s'~,moid colon were obtained  at the  time of partial 
colectomy and adjacent segments were incubated at 7°C and at 30°C. It can 
be seen that the rate of C'I production increases  with increasing  temperature. 
Because of the rapidity of C'1 production at higher temperatures it is difficult 
to obtain  precise measurements  at  closely  timed intervals.  For this  reason, 
most  of the  studies  on  in vitro  C'1  synthesis were performed  at  low  tem- 
perature. 
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Fxo. 2.  Effect of temperature on the rate of in vitro production of hemolytic.ally  active 
human C'1 by isolated segments of sigmoid colon. 
A segment of ileum obtained at surgery was capable of considerably more 
C'I  synthesis  (Fig.  3)  than  ileum  obtained  at  postmortem  (Fig.  1).  There 
was  no  detectable  production  of  hemolytically  active  C'1  by segments  of 
stomach, duodenum, jejunum, lung,  axJllary  lymph nodes, liver,  spleen,  and 
kidney incubated at 30°C. 
In a  single  experiment,  fetal tissues were obtained  at  the  time of a  total 
hysterectomy performed at 19 wk gestation. As in the adult, segments of the 
fetal small intestine  and colon but not of the thymus,  lung, kidney,  liver, 
spleen, or stomach  wcre capable of in vitro production  of hemolytically  ac- 
tive  C'I. COLTEN, GOP~N, BOP.SOS,  AND ~APP  599 
Ejffects of Inhibitors  of Protein Synthesis.--These  studies  were designed to 
test  the  effects of puromycin and  actinomycin D  on in vitro production of 
hemolytically active C'1  and on the incorporation of "C-labeled amino acids 
into C'l-like molecules (a molecule that binds to EA but not to E  and that 
can be removed from EA by treatment with EDTA). Adjacent segments of 
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FIo. 3. Effect of intffbitors  of protein synthesis on the production of hemolytically  active 
human C'I by segments of ileum at 7°C in medium 199. Upper figure: O, no inln'bitor; A, 
puromycin I0/~g/ml; A, tissue removed at 1' and reincubated in medium 199 lacking puro- 
mycin. Lower figure: O, no inhibitor; I"1, actinomycin D 10/~g/ml; B, tissue removed at 
T and reincubated in medium 199 lacking actinomycin  D. 
transverse colon were incubated at 10°C in medium 199 alone, in medium 199 
containing  15  #g/ml  of puromycin, in medium  199  cont~inlng  15  #g/ml of 
actinomycin D,  and in medium 199  containing 10 #g/ml of puromycin plus 
10 #g/ml of actinomycin D. At 23 hr of incubation, portions from each of the 
tissues incubated in the presence of inhibitors were removed and  incubated 
in medium 199 lacking inhibitors. In addition at that time, portions of tissues 
incubated in the presence of both inhibitors were transferred to medium 199 
containing either 10 #g/ml of puromycin or 10/~g/ml of actinomycin D. Table 600  SYNTHESIS OF HUMAN crl 
II summarizes the results of these experiments. The in vitro production of C'I 
was reduced by about 90 %  in the presence of actinomycin D  or in the pres- 
ence  of both  actinomycin D  and  puromycin.  Puromycin  alone reduced  C'1 
production  by about 60%.  Portions  of tissues  incubated  in  the  presence  of 
both inhibitors  and then further incubated  in puromycin alone resumed C'1 
production; the amount of C'1 produced was about 30% of that produced by 
tissues incubated in medium 199  alone. Segments of an ileum were incubated 
at 7°C in medium 199, medium 199 containing 10 ~g/ml actinomycin D, and 
TABLE II 
Effect of Purom~in and Actinomycin D on the Production of Hemolytically Active C'I 
by Segments of Human Transverse Colon 
Colon* 
Colon with puromycin (15 #g/ml) 
Puromycin removed at 23 hr 
Colon with actinomycin D (15/zg/ 
ml) 
Actinomycin D removed at 23 hr 
Colon with puromycin (10 #g/ml) 
and actinomycin D (10/~g/ml) 
Puromycin removed at 23 hr 
Actinomycin D removed at 23 hr 
Puromycin and actinomycin D re- 
moved at 23 hr 
C'1 molecules  (X 10-9)/100  mg of tissue 
Time of incubation, 
0  65 
O. 052 
0.052 
0.052 
20  42 
46.7  42.2 
18.7  6.1 
15.5 
6.2  2.8 
14.0 
2.4  1.6 
2.5 
9.9 
12.6 
24.5 
10.0 
25.0 
5.2 
9.4 
3.3 
4.5 
ii.5 
22.3 
* Tissues incubated in medium 199 at 10°C. 
medium 199  containing  10 #g/ml puromycin. As with the colon,  C'I produc- 
tion  by  the  ileum  was  reversibly inhibited  by puromycin  and  actinomycin 
D  (Fig. 3). 
The data presented in Table III show that puromycin and actinomycin D 
are  effective in  blocking incorporation  of a4C-labeled  amino  acids  into  C'I- 
like molecules. Furthermore, it can be seen that tissues from ascending, trans- 
verse,  and descending portions  of the colon and ileum are capable of incor- 
porating 14C-labeled  amino acids into  C'l-like molecules. As we have shown, 
these  tissues  were  also  capable of producing  hemolytically  active  C'1.  Un- COLTEN,  GORDON~ BORSOS,  AND  RAPP  601 
sensitized  erythrocytes  (E),  mixed  with  fragments  of  descending  or  trans- 
verse colon,  bound more than  twice as much  radioactivity as fragments  of 
ascending colon. A portion of the counts taken up by the unsensitized erythro- 
cytes could be removed by EDTA and therefore may be radiolabeled C'I. 
TABLE  HI 
Incorporation  of x~C-Amino Aci& into C'l-Like Molecules: Detection by Uptake on 
S~sitirc.d  Sheep Erythrocytes 
Ascending colon 
Ascending colon +  actinomycin 
D  (15 #g/ml) 
Descending colon 
Descending colon +  puromycin 
(15 ~g/ml) 
Transverse colon 
Transverse colon +  puromycin 
(15 #g/ml) 
Ileum 
Kidney 
Liver 
CPM on cells washed in 
VBS-sucrosc buffer,  ~ =  0.065 
gA 
L16 
22 
L31 
86 
L30 
94 
40 
2 
11 
E 
30 
23 
79 
95 
82 
81 
21 
4 
6 
EA-E 
86 
0 
52 
0 
48 
13 
19 
0 
5 
CPM on cells washed in 
0.01 M  EDTA buffer 
53 
36 
43 
32 
58 
43 
~ 
..._[  EA-E 
18 
18  18 
44 
33 
47 
31 
11 
4 
0 
22 
0 
2 
11 
12 
11 
0 
2 
E,  sheep  erythrocytes;  EA,  sheep  erythrocytes  sensitized  with  rabbit  anti-Forssman 
antibody. CPM, counts per min. 
All tissues were assayed for C'l-like molecules at 40 hr except the ileum which was assayed 
after 60 hr incubation. 
A control for nonspecific uptake of 14C-amino acids consisted of colon that contained pre- 
formed C'I incubated for less than 5 rain at 0°C with the 14C-amino  adds. No significant 
radiolabd was transferred to EA from tissue treated in this manner. 
DISCUSSION 
This is the first report of the in vitro synthesis of a  hemolytically active 
complement component in human tissue. We have found that, as in the guinea 
pig, hemolytically active C'I is produced in the tissues of the intestinal tract. 
In  guinea  pigs,  the  smaU intestine  was the only tissue  capable of in vitro 
synthesis of C'I. In contrast, the human C'I is synthesized in both the large 
intestine  and the ileum.  We were unable to demonstrate synthesis of signifi- 
cant  amounts  of human  C'I  in  the jejunum,  stomach,  liver,  kidney,  lung, 
spleen,  lymph node,  and  thymus. 602  SYNTHESIS  OF  ~-,u~AN  CPl 
Several  lines  of evidence indicate that in these experiments  we measured 
synthesis and not release  of preformed  C'I.  After elimination of  C'I  from 
tissues  by  treatment  with  EDTA,  we  found  between  a  50-1000-foid  in- 
crease in C'I activity. The production of C'I is highly temperature dependent 
and reversibly  inhibited by puromycin and actinomycin D.  C'I  production 
was not observed  in infarcted colon or in tissues  obtained more than 4-5 hr 
after  death  although  these  tissues  contained preformed  C'I.  Furthermore, 
incorporation of 14C  amino  acids  into  C'l-like molecules  accompanied  the 
production of hemolytically active C'1.  Stecher,  Morse,  and Thorbecke (10) 
reported that peritoneal macrophages and thoracic duct lymphocytes  of humans 
incorporated 14C-labeled amino  acids  into  C'lq  (lls  fragment of  C'I);  no 
attempts were made to demonstrate biological activity. Inhibitors of protein 
synthesis were not used in their studies and they pointed out that "the pos- 
sibility of artifacts created by the complexing of serum  proteins with other 
labeled tissue products cannot be ruled out." Complexing may occur between 
gamma globulin and the lls molecule (11). Thus, the results of our study and 
those of Stecher, Morse,  and Thorbecke are not comparable. 
Some  patients with congenital  agammaglobulinemia  have  reduced  serum 
C'1  (12, 13)  and C'lq levels (11-15);  it is not known,  however,  whether the 
low C'1 levels are the result of a defect in synthesis or an increased catabolic 
rate. Our studies demonstrate the feasibility of a direct study of synthesis of 
C'I in such patients. These studies would be of interest since associated  in- 
testinal pathology has been found in some patients with agammaglobulinemia 
(16). 
We have not yet identified  the  cell in the human intestine synthesizing 
C'1.  It has been suggested  that different parts of the C'1  molecule may be 
synthesized in different cell types (13). At present, however, there is no direct 
evidence  to  support  this  hypothesis. Our  data  clearly show  that  portions 
of the intestine are capable  of synthesizing and assembling the C'1 molecule. 
In the guinea pig, isolated epithelial cells of the small intestine were capable of 
producing hemolytically active C'1.  Work is in progress  to identify the cell 
or cell types producing human C'1. 
SU~ffARY 
Isolated segments of human colon and to a lesser extent ileum were capable 
of synthesizing hemolytically active C'1.  This conclusion was based  on the 
following evidence: 
After elimination of C'1 from tissue with EDTA, we found that segments of 
the intestinal tract in short-term organ culture showed a 50-1000-fold increase 
in C'1  activity. The rate of production of C'1 in human intestine was highly 
temperature dependent; C'1 production was reversibly inhibited by puromycin 
and actinomycin ]3.  Furthermore, 14C-labeled amino acids were incorporated COLTEN, GORDON~ BORSOS, AND RAPP  603 
into  molecules which  behaved  like  C'I. No  significant  C'I  h~  synthesis  was 
observed in isolated segments of jejunum, stomach, liver, kidney, lung, spleen, 
lymph node, and thymus. 
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The authors wish to thank Dr. Michael Cashel, Laboratory of Molecular Biology, National 
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